ArticleTrials2026

Circulating tumor DNA-based assessment of disease progression after liver resection or transplantation for metastatic colorectal cancer or hepatocellular carcinoma-study protocol for a randomized, controlled trial.

I Górzyńska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.